The Indian government plans to change laws governing drug trials to make violations by multinational corporations punishable and to improve compensation. Rules governing clinical studies under the Drugs and Cosmetics Act could be released this month. Trial investigators and sponsors would be required to address the medical management of subjects in cases of serious adverse events including death.

Related Summaries